Beliz B. Karaoglan

Eskisehir, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Survival Outcomes in ERBB2-Low vs ERBB2-Null Advanced Gastric Cancer.

Survival Outcomes in ERBB2-Low vs ERBB2-Null Advanced Gastric Cancer.

Journal: JAMA network open
Published: July 21, 2026

Decoding Immunotherapy Response in Colorectal Cancer: Translational Insights Beyond MSI.

Decoding Immunotherapy Response in Colorectal Cancer: Translational Insights Beyond MSI.

Journal: Cancers
Published: January 26, 2026

Immunotherapy expectations and knowledge in practice and clinical trials: a cross-sectional study.

Immunotherapy expectations and knowledge in practice and clinical trials: a cross-sectional study.

Journal: Immunotherapy
Published: January 14, 2026

Individualized Triplet Chemotherapy Decision-Making in Metastatic Colorectal Cancer: A Machine-Learning-Driven Study.

Individualized Triplet Chemotherapy Decision-Making in Metastatic Colorectal Cancer: A Machine-Learning-Driven Study.

Journal: Cancers
Published: October 15, 2025

Comments on "Folic acid deficiency as a modifiable risk factor for anastomotic leak in patients undergoing colorectal cancer surgery".

Comments on "Folic acid deficiency as a modifiable risk factor for anastomotic leak in patients undergoing colorectal cancer surgery".

Journal: Updates in surgery
Published: July 01, 2025

Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy.

Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy.

Journal: Scientific reports
Published: February 26, 2025

Combined preoperative and post-adjuvant-chemotherapy carcinoembryonic antigen levels are prognostic for early recurrence and survival in stage III colon cancer.

Combined preoperative and post-adjuvant-chemotherapy carcinoembryonic antigen levels are prognostic for early recurrence and survival in stage III colon cancer.

Journal: American journal of surgery
Published: December 03, 2024

Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors.

Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 25, 2024

Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis.

Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis.

Journal: Journal of gastrointestinal cancer
Published: October 27, 2024

Lymph Node Ratio (LNR) Discriminates Prognostication in pN1a-b and pN2 Stage-III Colon Cancer.

Lymph Node Ratio (LNR) Discriminates Prognostication in pN1a-b and pN2 Stage-III Colon Cancer.

Journal: Journal of Cancer
Published: September 27, 2024

Stage-specific characterization of "early-onset colorectal cancer": Localized and synchronous metastatic disease.

Stage-specific characterization of "early-onset colorectal cancer": Localized and synchronous metastatic disease.

Journal: International journal of cancer
Published: September 23, 2024

Treatment approaches and survival outcomes in elderly colorectal cancer patients: a single-center comparative study.

Treatment approaches and survival outcomes in elderly colorectal cancer patients: a single-center comparative study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 30, 2024
Showing 1-12 of 19

Last Updated: 09/26/2026